This RCGP accredited resource, composed of 11 clinical cases, assesses the user’s knowledge of the advanced treatment of Eczema.
Successful completion of the resource provides 1 hour of CPD delivered by Learna Ltd.
Eczema is a chronic, inflammatory skin condition which is thought to be due to an inherited defect in the barrier function of the skin. This predisposes the individual to allergic immune responses and with repeated immune stimulation can cause chronic inflammation.
About 15-20% of UK children suffer with atopic eczema which in most cases gets better as they get older. The specific age is not clear. However, it is prevalent in 2-10% of UK adults and in some cases the disease persists.
Children who have atopic eczema are predisposed to subsequently developing asthma and hay fever (allergic rhinitis and allergic conjunctivitis). They are also more likely to develop type I (immediate) hypersensitivity reactions to food. There is growing evidence that aggressive, early treatment of the eczema can reduce the severity or manifestation of subsequent atopic diseases.
On completion of this resource, you should: